Earlier quoted context omitted.
>Is the fake accounts thing overblown? From the article: >By Friday morning, Lilly stock had dropped by more than 5% from the day before. The Twitter stunt pulled down the stock price of other diabetes drugmakers, including Novo Nordisk and Sanofi. Lilly’s stock has yet to recover and, on Monday morning, remained down more than 4% over the past five days. I'm not normally one to defend drug makers, but when you're ta…
> The Twitter stunt pulled down the stock price of other diabetes drugmakers, including Novo Nordisk and Sanofi. It seems much, much more likely the stock loss was part of a larger market event than a specific Twitter stunt.
People's reaction are varied, this tweet actually resonates with people's beliefs much more strongly than what you might expect. For a lot of people, medicine that you need to continue living should be free. So I would say when this went viral, people at the very least go: "hmm...".
Couple that with reactions from politicians and suddenly you find yourself in a situation where the price of insulin is once again being questioned.
So imo, it's not just a funny tweet but more like a conversation starter and so it absolutely makes sense to me why this would be reflected in the stock price of insulin makers as a whole.